Conduit Pharmaceuticals has partnered with SARBORG Limited to utilize an advanced artificial intelligence and cybernetics platform aimed at improving various drug development processes, such as drug ...
Conduit Pharmaceuticals (CDT) partners with SARBORG Limited to leverage artificial intelligence and cybernetics for optimizing key drug development processes, including drug repurposing, discovery, ...
Neuralink expands trials to 21, advancing brain implants for paralysis and unveiling new cybernetic and Blindsight enhancements.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results